Algert Global LLC Mustang Bio, Inc. Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $167,880 - $218,635	-65,070 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.7 - $3.81 $9,801 - $13,830	3,630 Added 5.91%	65,070 $216,000
Q3 2020 Nov 16, 2020	BUY	$3.01 - $3.88 $134,336 - $173,164	44,630 Added 265.5%	61,440 $194,000
Q2 2020 Aug 12, 2020	SELL	$2.33 - $4.6 $17,172 - $33,902	-7,370 Reduced 30.48%	16,810 $53,000
Q1 2020 May 13, 2020	BUY	$1.91 - $4.52 $46,183 - $109,293	24,180 New	24,180 $65,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.